45 results on '"Edelman, A. J."'
Search Results
2. “Cancer’s a demon”: a qualitative study of fear and multilevel factors contributing to cancer treatment delays
3. Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patients
4. Individualised and non-contact post-mortem interval determination of human bodies using visible and thermal 3D imaging
5. Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
6. Correction to: A literature review and novel theoretical approach on the optical properties of whole blood
7. Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors
8. Training Leader Emotion Regulation and Leadership Effectiveness
9. A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)
10. Sexual Partner Notification of HIV Infection Among a National United States-Based Sample of HIV-Infected Men
11. Multiple socioecological factors influence timing of natal dispersal in kangaroo rats
12. A literature review and novel theoretical approach on the optical properties of whole blood
13. Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib
14. Patient and Provider-Reported Symptoms in the Post-cART Era
15. Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)
16. Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
17. The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines
18. Optimal Duration of Chemotherapy in Advanced Non-Small Cell Lung Cancer
19. Role of Non-Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
20. Bronchogenic carcinoma in solid organ transplant recipients
21. Management of common symptoms of advanced lung cancer
22. Management of paraneoplastic syndromes in lung cancer
23. Treatment options for brain metastases in patients with non-small-cell lung cancer
24. Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug
25. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma
26. Latin American trends in urban environmental management
27. The management of the patient undergoing combined modality therapy for locally advanced non-small cell lung cancer
28. Treatment options for brain metastases in patients with non-small cell lung cancer
29. Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection
30. Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines
31. Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial
32. Advanced non-small cell lung cancer
33. Phase I study of docetaxel and topotecan in patients with solid tumors
34. New approaches to treatment of metastatic bladder cancer
35. High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically
36. Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer
37. Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy: Dose, schedule, and route of administration
38. Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy
39. Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study
40. The Utility of Follow-up Testing After Curative Cancer Therapy: A Critical Review and Economic Analysis
41. Promising new agents in the treatment of non-small cell lung cancer
42. Erratum to: Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors
43. Ecologic and paleoecologic studies in the Feigne d'Artimont (Vosges, France)
44. Centralizing health care
45. Zur Kenntnis der lyophilen Kolloide: XV. Mitteilung. Der Einfluß hoher elektrolytkonzentration auf die Sole von Amylum und Gummiarabikum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.